MILWAUKEE, March 13, 2024 – ConsortiEX, an industry leader in compliance and patient-safety focused software and services for outsourcing and hospital pharmacies, is pleased to announce a new strategic partnership with LedgerDomain, a pioneering identity and secure messaging platform tailored for modern decentralized[...]
Oct. 21, 2021 - MILWAUKEE
The Institute for Safe Medication Practices (ISMP) recently held their annual Sterile Product Compounding Safety Summit. The goal of the summit is to continue the conversations around safe practices related to the use of sterile compounding workflow software, automated compounding devices and robotic compounding[...]
With the national rollout of the COVID-19 vaccine already underway, healthcare facilities nationwide are being faced with the challenge of balancing safety, documentation, and efficiency, in their protocols for vaccine distribution.
Several key industry players have issued responses to the FDA in regard to the recent draft guidance on the use of Product Identifiers, and the policy on grandfathered product, in compliance with the Drug Supply Chain Security Act (DSCSA).
On Sep. 9, 2018, the FDA released a Final Guidance regarding the use of product identifiers on packages and homogenous cases of product as mentioned in the Drug Supply Chain Security Act (DSCSA).
